On November 10, 2026, the U.S. Patent and Trademark Office issued a Notice of Decisions on Institution granting institution of inter partes review in IPR2026-00260. Amneal Pharmaceuticals, Inc. and Kashiv BioSciences, LLC (“Petitioners”) filed the IPR against U.S. Patent No. 12,030,959 (“the ’959 patent”), owned by Genentech, Inc. and Novartis…
